Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01443533 · ClinicalTrials.gov registry record · NA
Study of Birth Control Use After Childbirth
A NA study, sponsored by WakeMed Health and Hospitals.
- Completed
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT01443533 is a NA study that has completed, run by WakeMed Health and Hospitals. The registered enrollment target is 800 participants.
The verdict
NCT01443533, a NA study, has completed, sponsored by WakeMed Health and Hospitals.
- COMPLETED
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial that will evaluate the impact of a brief educational script on the method of birth control that women receive at their 6-week postpartum visit. The one-minute script ("LARC script") is given to women in the hospital during their postpartum admission. It informs patients about long-acting reversible contraceptive (LARC) methods, specifically the contraceptive implant and the intrauterine device. The investigators hypothesize that women who are randomized to receive the LARC script will be more likely to report that they are using a LARC method, when queried immediately after their six-week postpartum visit.
Interventions
- BEHAVIORAL LARC Script
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01443533
The ClinicalTrials.gov registry entry for NCT01443533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is WakeMed Health and Hospitals, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LARC Script is the first listed.
NCT01443533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01443533 about?
NCT01443533 is a clinical study titled "Study of Birth Control Use After Childbirth". This study is a randomized controlled trial that will evaluate the impact of a brief educational script on the method of birth control that women receive at their 6-week postpartum visit. The one-minute script ("LARC script") is given to women in the hospital during their postpartum admission. It in...
What is the current status of trial NCT01443533?
This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2011-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01443533?
The interventions under investigation include: LARC Script (BEHAVIORAL).
Who is sponsoring clinical trial NCT01443533?
This trial is sponsored by WakeMed Health and Hospitals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.